IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline glioma
Raphaël Collot(Oncode Institute), Anne Rios(Princess Máxima Center), Hendrikus C. R. Ariese(Oncode Institute), Anoek Zomer(Oncode Institute), Jens Bunt(Princess Máxima Center), Ellen J. Wehrens(Oncode Institute), Dannis G. van Vuurden(Amsterdam UMC Location Vrije Universiteit Amsterdam), Mariëtte E.G. Kranendonk(Princess Máxima Center), Jennifer R. Cochran(Stanford University), Thijs J M van den Broek(Princess Máxima Center), Cristian Ruiz-Moreno(Radboud University Nijmegen), Emma Bokobza(Inserm), Daan J. Kloosterman(Oncode Institute), Amber K. L. Wezenaar(Oncode Institute), Brigit M. te Pas(Princess Máxima Center), Amal Jeiroshi(Princess Máxima Center), Hendrik G. Stunnenberg(Radboud University Nijmegen), Esther Hulleman(Princess Máxima Center), Femke C.A. Ringnalda(Princess Máxima Center), Hannah Johnson(Princess Máxima Center), Ravian L. van Ineveld(Princess Máxima Center), Pierre A. Robe(University Medical Center Utrecht), Marcel Kool(German Cancer Research Center), Marc van de Wetering(Princess Máxima Center), Celina Honhoff(Oncode Institute), Heggert G. Rebel(Princess Máxima Center), Britt M. T. Vervoort(Princess Máxima Center)
Cited by 3
Related Papers
The changing epidemiology of congenital heart disease
|Nature Reviews Cardiology|2010|757
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
|Nature Chemical Biology|2021|579
Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells
|Proceedings of the National Academy of Sciences|2010|532